| ²é¿´: 4303 | »Ø¸´: 7 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
michael_zykгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
µ¥ÏõËáÒìɽÀæõ¥Æ¬µÄÔÑг§¼ÒÊÇË£¿
|
||
|
ÇëÎʸ÷λ³æÓÑ£¬ËÖªµÀµ¥ÏõËáÒìɽÀæõ¥Æ¬£¨Isosorbide Mononitrate Tablets£©µÄÔÑг§¼ÒÊÇË£¬×îÔçÔÚÄĸö¹ú¼ÒÉÏÊеģ¿ÔÑÐÒ©ÊÇ·ñÄÜÂòµ½£¿ ÎÒÐèÒªÖªµÀÕâЩÏûÏ¢µÄÀ´Ô´Óë³ö´¦¡£ ¶àл£¡ |
» ²ÂÄãϲ»¶
°ÍÀèÈø¿ËÀ×´óѧÓë¹ú¼ÒÁôѧ»ù½ðίºÏ×÷²©Ê¿Ñо¿ÉúÏîÄ¿-Ö¬ÖÊÄÉÃ×Ò©Îï/ÉúÎï²ÄÁÏ/¶à·ÓµÝËÍ
ÒѾÓÐ10È˻ظ´
ÖйúÒ©¿Æ´óѧ2026Èëѧ²©Ê¿£¬Ò©ÎïºÏ³ÉºÍÉè¼Æ¾Ñ飬·ÅÉ仯ѧ¼°·ÅÉäҽѧÑо¿
ÒѾÓÐ25È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ229È˻ظ´
ʹÓÃMolAICal½øÐжàëÄÐéÄâɸѡ½Ì³Ì-ͬÑùÊÊÓÃÓÚµ°°×ÖʺͺËËáµÄÐéÄâɸѡ
ÒѾÓÐ1È˻ظ´
ʹÓÃMolAICal¼ÆËãÒ©Îﻯѧ¹ýÂËÆ÷MCFs¼°MCE-18ÃèÊö·û
ÒѾÓÐ0È˻ظ´
ʹÓÃMolAICal·¢ÏÖµ°°×ÊÜÌåDZÔڵĻîÐÔ¿Ú´ü¼°Î»µã
ÒѾÓÐ0È˻ظ´
»ªÀíҩѧѧ˶Çóµ÷¼Á£¬×Ü·Ö324
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ0È˻ظ´
°ÄÃÅÀí¹¤´óѧÈ˹¤ÖÇÄÜÒ©Îï·¢ÏÖÖÐÐÄÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú£¨ÉêÇë-¿¼ºËÖÆ£©
ÒѾÓÐ10È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
µ¥ÏõËáÒìɽÀæõ¥¾§ÐÎÎÊÌâ¼°ËûµÄƬ¼Á¹¤ÒÕ´¦·½
ÒѾÓÐ3È˻ظ´
¹ØÓÚ5-µ¥ÏõËáÒìɽÀæõ¥¼ÓÈÈ·Ö½âµÄÆÆ»µÐÔÊÔÑé
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿ÃÀÍÐÂå¶û ¡¢µ¥ÏõËáÒìɽÀæõ¥ ¡¢ÑÎËáÄÉÂåͪ ¡¢ÒÒõ£¹Èõ£°·µÈÄÜÄÍÊܸßÎÂÃð¾úÂ
ÒѾÓÐ4È˻ظ´
mrzouhao
ľ³æÖ®Íõ (ÎÄ̳¾«Ó¢)
- DRDEPI: 1
- Ó¦Öú: 179 (¸ßÖÐÉú)
- ¹ó±ö: 0.108
- ½ð±Ò: 100741
- É¢½ð: 11601
- ºì»¨: 134
- ɳ·¢: 22
- Ìû×Ó: 46740
- ÔÚÏß: 4406.2Сʱ
- ³æºÅ: 201350
- ×¢²á: 2006-02-28
- רҵ: Ò©¼Áѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
michael_zyk: ½ð±Ò+2, ¡ïÓаïÖú, Óеã°ïÖú 2012-10-12 09:40:01
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
michael_zyk: ½ð±Ò+2, ¡ïÓаïÖú, Óеã°ïÖú 2012-10-12 09:40:01
| Isosorbide mononitrate is a drug used principally in the treatment of angina pectoris[1] and acts by dilating the blood vessels so as to reduce the blood pressure. It is sold by AstraZeneca under the trade name Imdur, and marketed in the UK under the trade names: Monosorb, Chemydur. In India this drug is available under the brand names of Ismo,Isonorm Monotrate, Solotrate, and Monit. |
4Â¥2012-10-06 00:12:12
yaowuyanfa
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1.8
- Ìû×Ó: 26
- ÔÚÏß: 12.2Сʱ
- ³æºÅ: 2042663
- ×¢²á: 2012-10-04
- רҵ: Ò©¼Áѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
´ÓÍ·¿ªÊ¼: ½ð±Ò+2, ¸Ðл²ÎÓë 2012-10-04 23:02:53
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
´ÓÍ·¿ªÊ¼: ½ð±Ò+2, ¸Ðл²ÎÓë 2012-10-04 23:02:53
|
http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm£» http://www.accessdata.fda.gov/sc ... RBIDE%20MONONITRATE£» |
2Â¥2012-10-04 15:26:46
michael_zyk
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 6
- Ìû×Ó: 30
- ÔÚÏß: 5.5Сʱ
- ³æºÅ: 2009396
- ×¢²á: 2012-09-18
- רҵ: ºÏ³ÉÒ©Îﻯѧ
3Â¥2012-10-05 09:04:11
michael_zyk
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 6
- Ìû×Ó: 30
- ÔÚÏß: 5.5Сʱ
- ³æºÅ: 2009396
- ×¢²á: 2012-09-18
- רҵ: ºÏ³ÉÒ©Îﻯѧ
5Â¥2012-10-06 14:09:46













»Ø¸´´ËÂ¥